Logo
Search
HOME
ARCHIVE
SIGN IN
SUBSCRIBE
UPGRADE

FEATURED


📈 The Divergence: Why Kodiak Soared (+12%) vs. Immunome Sank

Dec 18, 2025

•

7 min read

📈 The Divergence: Why Kodiak Soared (+12%) vs. Immunome Sank

Biotech Financing Returns (Selectively) | 📉 Pfizer's "Value Trap" | 💊 A "Bankrupt" Drug Wins

BioMed Nexus
BioMed Nexus

THE LATEST


Dec 17, 2025

•

7 min read

🟢 GSK Wins. 🔴 Aldeyra Delays. 🧟 XOMA's "Zombie" Play.

📉 Pfizer Falls -5% | 💰 Sobi's $950M Bet | ⚠️ The "Holiday" Binaries

Dec 16, 2025

•

10 min read

🟢 Enhertu Approved. 🔴 Aldeyra Delayed. 🏆 Roche Wins.

The Full SABCS Debrief | 📉 Sanofi's Phase 3 Miss | ⚠️ Binary Risks Shift

Dec 15, 2025

•

7 min read

Innoviva Approved + Aldeyra's Final Verdict

⚠️ The Week Ahead (ALDX) | 🏆 BioCryst & Innoviva Wins | 📉 Recursion's Fade

TRENDING


Google Enters the Clinic + BioCryst Decision Day

Google Enters the Clinic + BioCryst Decision Day

🔴 Regulatory Verdicts Today | 🧪 Isomorphic's First Trial | 🤖 Medra's $52M Robots

PDUFA Watch: BioCryst & Amgen Decisions + Post-CPI Rally

PDUFA Watch: BioCryst & Amgen Decisions + Post-CPI Rally

⚠️ Regulatory Verdicts Tomorrow | 📈 Structure Analyst Upgrades | 🧪 Kelonia's "In Vivo" Win

📊 Chart of the Week: The "Obesity Gap" + Pfizer's New $2B Bet

📊 Chart of the Week: The "Obesity Gap" + Pfizer's New $2B Bet

Syndax Rallies | Incyte's Lymphoma Win | CPI Volatility Ahead

🚀 Obesity Shock: Wave (+147%) & Structure (+102%) Redefine the Market

🚀 Obesity Shock: Wave (+147%) & Structure (+102%) Redefine the Market

Terns Challenges Novartis | Dyne's DMD Win | $750M in New Raises

🩸 ASH Shock: Vertex & Arcellx Win + The Oral GLP-1 Verdict (Today)

🩸 ASH Shock: Vertex & Arcellx Win + The Oral GLP-1 Verdict (Today)

Structure Data Imminent | Capricor's 371% Week | Dyne's DMD Readout

🧪 Deal Rush: SciNeuro's $53M Win + The ASH 2025 Preview

🧪 Deal Rush: SciNeuro's $53M Win + The ASH 2025 Preview

Capricor Target Raised to $60 | Intuitive Shares Slide | ImPact’s Urology Win

The 500% Gainer: Capricor’s Win + Medtronic’s Robot War

The 500% Gainer: Capricor’s Win + Medtronic’s Robot War

BMS Stumbles | BioCryst Deal Clears | The New "Data Premium" Trade

⚠️ FDA Shock: Pazdur Out + The $150M Gene Writing Bet

⚠️ FDA Shock: Pazdur Out + The $150M Gene Writing Bet

Tariffs hit 0% | Otsuka's Renal Win | Small Cap PRV is Back

SUBSCRIBE TO OUR NEWSLETTER

Stay on the Cutting Edge of Biotech, MedTech, and Pharma.

Home

Archive

Authors

Subscribe

Upgrade

Sign Up

Login

Update Password

Reset Password

Search

Profile

STAY CONNECTED

© 2025 BioMed Nexus.

Report abuse

Privacy policy

Terms of use

Powered by beehiiv